4202101

PRONOVA^® SLG 100

sodium alginate solution, M_w 150-250 kDa, guluronate monomer units ≥60 %

• UNSPSC-Code: 12162002
• NACRES: NA.25

Eigenschaften

• Qualitätsniveau: 100
• Sterilität: sterile (Total viable count (CFU/g))
• Form: powder
• Mol-Gew.: M_w 150-250 kDa
• Zusammensetzung: guluronate monomer units, ≥60% ; G/M ratio, ≥1
• Verunreinigungen: ≤100 EU/g Endotoxins
• pH-Wert: 5.5-8.5 (20 °C, 1% in water)
• Viskosität: 100-300 mPa.s, 1 % in water(20 °C)

Beschreibung

Anwendung

Examples of Pronova Alginates applications include: encapsulation of living cells and therapeutic proteins for cell therapy medications, cryoprotectant, bone putty binder for tissue engineering, 3D bioprinting, foams and cell tissue scaffolds, hydrogels, advanced drug delivery and implants, wound management, and medical devices.

SLG-100 is made from an alginate where over 60% of the monomer units are guluronate and is a highly purified and well-characterized sodium alginate. The molecular weight for PRONOVA SLG-100 is in the 200000 – 300000 g/mol range. The ultra low levels of endotoxins, proteins and product sterility allows for a big variety of in vitro and in vivo applications.

Rechtliche Hinweise

Product of Dupont Nutrition USA, Inc.

PRONOVA is a registered trademark of International N&H USA, Inc.

Haftungsausschluss

NOT FOR USE IN HUMANS

Sicherheitshinweise

• Lagerklassenschlüssel: 11 - Combustible Solids
• WGK: WGK 1
• Flammpunkt (°F): Not applicable
• Flammpunkt (°C): Not applicable